FXYD3 and neoplasm: To understand the poor outcome in FXYD3 high KIRC patients, we examined the characteristics of the TME between FXYD3 high and low patients in terms of TILs, tumor purity, and abundance of stromal cells using the ESTIMATE algorithm [19].